159 related articles for article (PubMed ID: 1892680)
21. Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis.
Chang TC; Hsieh F; Lai CH; Tseng CJ; Cheng HH; Li CL; Michael BJ; Soong YK
Cancer Chemother Pharmacol; 1996; 37(3):279-85. PubMed ID: 8529290
[TBL] [Abstract][Full Text] [Related]
22. Sustained-release metoclopramide plus methylprednisolone versus placebo plus methylprednisolone as antiemetic prophylaxis during non-cisplatin chemotherapy. A randomized double-blind cross-over trial.
Hansen O; Pfeiffer P; Madsen B; Andersen I; Hansen B; Mathiesen B
Acta Oncol; 1996; 35(1):57-61. PubMed ID: 8619941
[TBL] [Abstract][Full Text] [Related]
23. Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients.
Dogliotti L; Antonacci RA; Pazè E; Ortega C; Berruti A; Faggiuolo R
Drugs; 1992; 43 Suppl 3():6-10. PubMed ID: 1380432
[TBL] [Abstract][Full Text] [Related]
24. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S
J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536
[TBL] [Abstract][Full Text] [Related]
25. Treatment of cisplatin-related nausea and vomiting with a combination of ondansetron and metoclopramide: a pilot study.
Gebbia V; Testa A; Cannata G; Gebbia N
Anticancer Drugs; 1996 Sep; 7(7):734-7. PubMed ID: 8949983
[TBL] [Abstract][Full Text] [Related]
26. Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
J Clin Oncol; 1997 Jan; 15(1):124-30. PubMed ID: 8996133
[TBL] [Abstract][Full Text] [Related]
27. Randomized trial for the control of acute vomiting in cisplatin-treated patients: high-dose metoclopramide with dexamethasone and lorazepam as adjuncts versus high-dose alizapride plus dexamethasone and lorazepam. Study of the incidence of delayed emesis.
Moreno I; Rosell R; Abad-Esteve A; Barnadas A; Carles J; Ribelles N
Oncology; 1991; 48(5):397-402. PubMed ID: 1745488
[TBL] [Abstract][Full Text] [Related]
28. A prospective randomized double-blind crossover study comparing the antiemetic activity of alizapride and metoclopramide in patients receiving cisplatin chemotherapy.
Basurto C; Roila F; Del Favero A; Ballatori E; Minotti V; Tonato M
Cancer Invest; 1988; 6(5):475-9. PubMed ID: 3063335
[TBL] [Abstract][Full Text] [Related]
29. Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapy.
Osoba D; Erlichman C; Willan AR; Levitt M; Pater JL
Clin Invest Med; 1986 Nov; 9(4):225-31. PubMed ID: 3542325
[TBL] [Abstract][Full Text] [Related]
30. [Randomized cross-over study on the effects of methylprednisolone, metoclopramide and droperidol on the control of nausea and vomiting associated with cis-platinum chemotherapy].
Niijima T; Isurugi K; Akaza H; Kondo Y; Kawabe K; Fujita K; Koiso K; Yokoyama M; Kinoshita K; Aso Y
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2376-82. PubMed ID: 3729492
[TBL] [Abstract][Full Text] [Related]
31. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
[TBL] [Abstract][Full Text] [Related]
32. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
Bhatia A; Tripathi KD; Sharma M
Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
[TBL] [Abstract][Full Text] [Related]
33. Effective control of cisplatin induced emesis by combination drug regimen.
Misra R; Agarwal N
Indian J Cancer; 1994 Mar; 31(1):19-22. PubMed ID: 8063331
[TBL] [Abstract][Full Text] [Related]
34. Intravenous metoclopramide: prevention of chemotherapy-induced nausea and vomiting. A preliminary evaluation.
Strum SB; McDermed JE; Pileggi J; Riech LP; Whitaker H
Cancer; 1984 Mar; 53(6):1432-9. PubMed ID: 6692333
[TBL] [Abstract][Full Text] [Related]
35. Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. The Italian Group for Antiemetic Research.
J Clin Oncol; 1993 Dec; 11(12):2396-404. PubMed ID: 8246029
[TBL] [Abstract][Full Text] [Related]
36. Randomized comparison of the antiemetic efficacy of a serotonin type 3 receptor antagonist (MDL 72,222) with a high-dose metoclopramide regimen.
Homesley HD; Hahne WF; McLees B; Heck K; Barrett RJ; Lentz SS; Woodlief L; Lovelace JV
Am J Clin Oncol; 1993 Apr; 16(2):175-9. PubMed ID: 8452114
[TBL] [Abstract][Full Text] [Related]
37. Combination therapy with granisetron, methylprednisolone and droperidol as an antiemetic prophylaxis in CDDP-induced delayed emesis for gynecologic cancer.
Sagae S; Ishioka S; Fukunaka N; Terasawa K; Kobayashi K; Sugimura M; Nishioka Y; Kudo R; Minami M
Oncology; 2003; 64(1):46-53. PubMed ID: 12457031
[TBL] [Abstract][Full Text] [Related]
38. [Anti-emetic treatment with metoclopramide and other drugs during CDDP therapy].
Kodama N; Furuse K; Kawahara M; Arai R; Tsuruta S; Hayashi S; Kiyota T
Gan To Kagaku Ryoho; 1987 Jan; 14(1):159-64. PubMed ID: 3800403
[TBL] [Abstract][Full Text] [Related]
39. Intravenous metoclopramide. An effective antiemetic in cancer chemotherapy.
Strum SB; McDermed JE; Opfell RW; Riech LP
JAMA; 1982 May; 247(19):2683-6. PubMed ID: 7043002
[TBL] [Abstract][Full Text] [Related]
40. A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues.
Cunningham D; Bradley CJ; Forrest GJ; Hutcheon AW; Adams L; Sneddon M; Harding M; Kerr DJ; Soukop M; Kaye SB
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):685-9. PubMed ID: 2838294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]